AJG vs EBS · P/E 33, rev $11.55B vs rev $1.04B
Arthur J Gallagher & Co (AJG) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AJG revenue for 2024-12-31 was $11.55B. Net income was $1.47B. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AJG and EBS stock pages for the full models.
Not investment advice.